Stockscreener 앱 받기
2.87
5.28%
-0.16
시간 외 거래:
2.88
0.010
+0.35%
전일 마감가:
$3.03
열려 있는:
$3.01
하루 거래량:
1.79M
Relative Volume:
0.46
시가총액:
$406.26M
수익:
$4.21M
순이익/손실:
$-97.67M
주가수익비율:
-3.086
EPS:
-0.93
순현금흐름:
$-70.76M
1주 성능:
-10.03%
1개월 성능:
+25.88%
6개월 성능:
-29.14%
1년 성능:
-43.50%
1일 변동 폭
$2.85
$3.03
1주일 범위
$2.85
$3.19
52주 변동 폭
$2.01
$6.33
Absci Corp Stock (ABSI) Company Profile
명칭
Absci Corp
전화
(360) 949-1041
주소
18105 SE MILL PLAIN BLVD, VANCOUVER
ABSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.87 | 406.26M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-22 | 개시 | Needham | Buy |
| 2024-10-02 | 개시 | Guggenheim | Buy |
| 2024-07-03 | 개시 | Morgan Stanley | Overweight |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | 개시 | H.C. Wainwright | Buy |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-07-18 | 개시 | Truist | Buy |
| 2022-03-02 | 재개 | Cowen | Market Perform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-11-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-08-16 | 개시 | BofA Securities | Neutral |
| 2021-08-16 | 개시 | Cowen | Market Perform |
| 2021-08-16 | 개시 | Credit Suisse | Outperform |
| 2021-08-16 | 개시 | Stifel | Hold |
모두보기
Absci Corp 주식(ABSI)의 최신 뉴스
Marshall Wace LLP Reduces Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
128,400 Shares in Absci Co. (NASDAQ:ABSI) Acquired by Jump Financial LLC - MarketBeat
Absci (NASDAQ:ABSI) Stock Price Expected to Rise, KeyCorp Analyst Says - MarketBeat
Absci price target raised to $9 from $5 at KeyBanc - TipRanks
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025 - GlobeNewswire
AI Drug Pioneer Absci Reveals Q1 2025 Results Date: Key Updates Coming May 13 - Stock Titan
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing - Benzinga
Raymond James Financial Inc. Acquires Shares of 193,926 Absci Co. (NASDAQ:ABSI) - MarketBeat
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday - Benzinga
Absci (NASDAQ:ABSI) Earns Buy Rating from Needham & Company LLC - MarketBeat
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements - Benzinga
Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)Absci (NASDAQ:ABSI) - Benzinga
ADAR1 Capital Management LLC Has $413,000 Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market - Seeking Alpha
Top 5 AI & Digital Biotech Companies (April 2025) - Securities.io
Absci stock touches 52-week low at $2.45 amid market challenges - Investing.com
Absci stock touches 52-week low at $2.45 amid market challenges By Investing.com - Investing.com South Africa
Which Healthcare Stock Is the Best Buy Right Now? - MarketBeat
Absci to Participate in Upcoming Investor Conferences - GlobeNewswire
AI Drug Pioneer Absci Takes Center Stage at Two Elite Healthcare Conferences - Stock Titan
Royce & Associates LP Grows Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat
HC Wainwright Issues Negative Estimate for Absci Earnings - MarketBeat
Absci Corp’s Earnings Call: Balancing Innovation and Financial Challenges - MSN
KeyBanc maintains Absci stock Overweight rating, $5 target By Investing.com - Investing.com South Africa
KeyBanc maintains Absci stock Overweight rating, $5 target - Investing.com
Platinum Investment Management Ltd. Boosts Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci (NASDAQ:ABSI) Given "Buy" Rating at HC Wainwright - MarketBeat
Absci (NASDAQ:ABSI) Given Buy Rating at Needham & Company LLC - MarketBeat
Absci (NASDAQ:ABSI) Releases Quarterly Earnings Results - MarketBeat
Absci (NASDAQ:ABSI) Announces Earnings Results - MarketBeat
Absci Corporation (NASDAQ:ABSI) Q4 2024 Earnings Call Transcript - Insider Monkey
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus
Nikko Asset Management Americas Inc. Boosts Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
H.C. Wainwright maintains $7 target on Absci stock with Buy rating - Investing.com Australia
Absci Corp (ABSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):